» Articles » PMID: 37554903

Emerging Zoonotic Diseases and COVID-19 Pandemic: Global Perspective and Indian Scenario

Overview
Publisher Wolters Kluwer
Specialty Medical Education
Date 2023 Aug 9
PMID 37554903
Authors
Affiliations
Soon will be listed here.
Abstract

The current coronavirus disease 2019 (COVID-19) pandemic is one example of the scores of zoonotic diseases responsible for various outbreaks resulting in the deaths of millions of people for centuries. The COVID-19 pandemic has broken the age-old healthcare infrastructure and led to utter chaos. In the shadow of this pandemic, other zoonotic infections like the nipah virus, monkeypox, and langya virus, to name a few, have been neglected. Hence, outbreaks caused by such zoonotic viruses are rising in their endemic areas, like the Indian subcontinent. The mortality and morbidity due to such zoonoses are greater than usual due to the shortage of healthcare professionals caused by the COVID-19 crisis. Due to the lack of vaccines and therapeutics directed against this viral infection, treatment of patients is limited to supportive management and prevention, making preparedness for these potential zoonotic viral outbreaks essential. This paper highlights some of these zoonotic infections, which perpetuated and wreaked havoc while the world was occupied with containing the COVID-19 pandemic.

Citing Articles

Threats of zoonotic pathogens in food chain: Current status and gaps in India.

Das M, Ojha A, Albert V, Borah S, Ramamurthy T, Das S Heliyon. 2025; 11(1):e41240.

PMID: 39801994 PMC: 11721238. DOI: 10.1016/j.heliyon.2024.e41240.


Occurrence of selected Covid-19 drugs in surface water resources: a review of their sources, pathways, receptors, fate, ecotoxicity, and possible interactions with heavy metals in aquatic ecosystems.

Maremane S, Belle G, Oberholster P, Omotola E Environ Geochem Health. 2024; 47(1):3.

PMID: 39607624 PMC: 11604763. DOI: 10.1007/s10653-024-02293-9.


Assessing multi-target antiviral and antioxidant activities of natural compounds against SARS-CoV-2: an integrated in vitro and in silico study.

Al Balawi A, Eldiasty J, Mosallam S, El-Alosey A, Elmetwalli A Bioresour Bioprocess. 2024; 11(1):108.

PMID: 39604740 PMC: 11602940. DOI: 10.1186/s40643-024-00822-z.


Molecular Engineering of Virus Tropism.

He B, Wilson B, Chen S, Sharma K, Scappini E, Cook M Int J Mol Sci. 2024; 25(20).

PMID: 39456875 PMC: 11508178. DOI: 10.3390/ijms252011094.


Disease X and COVID-19: turning lessons from India and the world into policy recommendations.

Bardhan M, Ray I, Roy S, Roy P, Thanneeru P, Twayana A Ann Med Surg (Lond). 2024; 86(10):5914-5921.

PMID: 39359799 PMC: 11444564. DOI: 10.1097/MS9.0000000000002391.


References
1.
Kabuga A, El Zowalaty M . A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria. J Med Virol. 2018; 91(4):533-540. DOI: 10.1002/jmv.25348. View

2.
Aborode A, Wireko A, Mehta A, Abdul-Rahman T, Nansubuga E, Kundu M . Concern over Nipah virus cases amidst the COVID-19 pandemic in India. J Med Virol. 2022; 94(8):3488-3490. PMC: 9088462. DOI: 10.1002/jmv.27745. View

3.
Tiwari R, Dhama K, Sharun K, Yatoo M, Singh Malik Y, Singh R . COVID-19: animals, veterinary and zoonotic links. Vet Q. 2020; 40(1):169-182. PMC: 7755411. DOI: 10.1080/01652176.2020.1766725. View

4.
Yadana S, Valitutto M, Aung O, Hayek L, Yu J, Myat T . Assessing Behavioral Risk Factors Driving Zoonotic Spillover Among High-risk Populations in Myanmar. Ecohealth. 2023; 20(1):31-42. PMC: 10230129. DOI: 10.1007/s10393-023-01636-9. View

5.
Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S . Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol. 2020; 17(6):613-620. PMC: 7091888. DOI: 10.1038/s41423-020-0400-4. View